CN108379350A - A kind of eczema ointment and preparation method thereof - Google Patents
A kind of eczema ointment and preparation method thereof Download PDFInfo
- Publication number
- CN108379350A CN108379350A CN201810520335.4A CN201810520335A CN108379350A CN 108379350 A CN108379350 A CN 108379350A CN 201810520335 A CN201810520335 A CN 201810520335A CN 108379350 A CN108379350 A CN 108379350A
- Authority
- CN
- China
- Prior art keywords
- eczema
- ointment
- eczema ointment
- preparation
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 111
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 105
- 239000002674 ointment Substances 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 235000009508 confectionery Nutrition 0.000 claims abstract description 25
- 240000005250 Chrysanthemum indicum Species 0.000 claims abstract description 23
- 239000002904 solvent Substances 0.000 claims abstract description 21
- 235000018959 Chrysanthemum indicum Nutrition 0.000 claims abstract description 20
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 20
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 20
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 20
- 239000002270 dispersing agent Substances 0.000 claims abstract description 20
- 238000001704 evaporation Methods 0.000 claims abstract description 20
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000010992 reflux Methods 0.000 claims abstract description 19
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 18
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 18
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 18
- 239000004863 Frankincense Substances 0.000 claims abstract description 18
- 239000009636 Huang Qi Substances 0.000 claims abstract description 17
- 241000218682 Pseudolarix amabilis Species 0.000 claims abstract description 17
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 15
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 15
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 15
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 15
- 241000931705 Cicada Species 0.000 claims abstract description 15
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 15
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 15
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 15
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 15
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 14
- 235000012907 honey Nutrition 0.000 claims abstract description 14
- 238000002604 ultrasonography Methods 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 25
- 239000002994 raw material Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- 239000004411 aluminium Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 238000007598 dipping method Methods 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229960001967 tacrolimus Drugs 0.000 claims description 6
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 241000251468 Actinopterygii Species 0.000 claims description 5
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 5
- 244000025254 Cannabis sativa Species 0.000 claims description 5
- 244000030166 artemisia Species 0.000 claims description 5
- 240000006891 Artemisia vulgaris Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 21
- 208000003251 Pruritus Diseases 0.000 abstract description 16
- 240000001851 Artemisia dracunculus Species 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000001139 anti-pruritic effect Effects 0.000 abstract description 6
- 239000003908 antipruritic agent Substances 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000001114 myogenic effect Effects 0.000 abstract description 6
- 238000005469 granulation Methods 0.000 abstract description 5
- 230000003179 granulation Effects 0.000 abstract description 5
- 230000008961 swelling Effects 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 4
- 230000017074 necrotic cell death Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 230000001900 immune effect Effects 0.000 abstract description 3
- 229920002472 Starch Polymers 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 27
- 230000001154 acute effect Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 206010040882 skin lesion Diseases 0.000 description 7
- 231100000444 skin lesion Toxicity 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 239000003862 glucocorticoid Substances 0.000 description 6
- 206010037844 rash Diseases 0.000 description 6
- 241001116389 Aloe Species 0.000 description 5
- 208000010201 Exanthema Diseases 0.000 description 5
- 206010033733 Papule Diseases 0.000 description 5
- 235000011399 aloe vera Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 201000005884 exanthem Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000000306 recurrent effect Effects 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 239000008338 calamine lotion Substances 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000002955 immunomodulating agent Substances 0.000 description 3
- 229940121354 immunomodulator Drugs 0.000 description 3
- 230000002584 immunomodulator Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052958 orpiment Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 102000004631 Calcineurin Human genes 0.000 description 1
- 108010042955 Calcineurin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- QBYFCXBVWQQXFH-UHFFFAOYSA-N acaciin Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4OC6OCC(O)C(O)C6O)cc3O2 QBYFCXBVWQQXFH-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- KASDHRXLYQOAKZ-ZPSXYTITSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-ZPSXYTITSA-N 0.000 description 1
- 229960005330 pimecrolimus Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Animal Husbandry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of eczema ointments and preparation method thereof, including following preparation process：1) cicada slough, Radix Astragali, Radix Angelicae Sinensis, frankincense, myrrh, waist Huang and Golden Larch Bark are crushed, impregnates, is heated at reflux；Filtering obtains Chinese medical extract I after evaporating solvent；2) wormwood and mother chrysanthemum decoct, and water extract II is obtained after concentration；3) Chinese medical extract I, water extract II, lotus nut starch and honey are mixed, confection III is made；4) glycerin monostearate and Aloe Vera Gel are mixed and carries out ultrasound, heating, obtain solution IV；5) his Mack department and dispersant are merged with mixed liquor, eczema ointment coarse fodder is obtained after evaporating solvent；6) by coarse fodder it is high-pressure homogeneous after to get to eczema ointment.Eczema ointment produced by the present invention has removing dampness to stop itchin, immunological regulation, anti-inflammatory and antipruritic, clearing heart fire, mental-tranquilization, regulating the qi flowing in the channels of invigorating blood circulation relieves pain, dispersing swelling and dissipating binds myogenic, for festering caused by itch, warts, can removing necrosis, promoting granulation the effects that, and the root that can cure the disease is without any side effects.
Description
Technical field
The present invention relates to field of medicaments more particularly to a kind of eczema ointment and preparation method thereof.
Background technology
Eczema is a kind of scytitis reaction of the acute pruritus caused by a variety of internal and external factors.Eczematosis is because of complexity, often
For internal and external reasons interaction result.Internal cause for example chronic digestive system disease, stress, insomnia, over fatigue, emotional change,
Endocrine disorder, infection, dysbolism etc., external cause such as living environment, climate change, food etc. can influence the hair of eczema
It is raw.Environmental stimuli such as daylight, cold, drying, sweltering heat, hot water is scalded and various animal skins, plant, cosmetics, soap, people
Making fiber etc. can induce, and be a kind of delayed allergy caused by the inside and outside factor of complexity.
It is divided into acute, subacute, chronic three phases by skin lesion performance.Acute eczema：Skin lesion is just big for most intensive grain grains
Small papule, papulo-vesicle or phlysis, substrate flush, gradually fusion is in blocks, due to scratching, papule, papulo-vesicle or blister top
It is become apparent from apparent dotted exudation and small rotten to the corn face, blur margin, such as secondary infection, inflammation after scratching, warts, purulence can be formed
Scab, epifolliculitis, furuncle etc..Feel violent itch；After being apt to occur in head, ear, distal limbs, scrotum, crissum etc., multipair title publication.
Subacute eczema：After acute eczema inflammation mitigates, skin lesion is based on small papule, incrustation and the scales of skin that peel off, rarely seen a small amount of papulo-vesicle and gruel
It is rotten, still there is violent itch.Chronic eczema：Often switch to chronic eczema because acute, subacute eczema recurrent exerbation is not cured；Also it can open
Begin be chronic eczema, show as illing skin and thicken, infiltrate, brownish red or pigmentation, rough surface, cover the scales of skin that peel off or because
It scratches and forms a scab, feel acute pruritus, be common in shank, hand, foot, fossa cubitalis, popliteal nest, vulva, anus etc..The course of disease is indefinite, easily
Recurrence, does not recover for a long time.
The range involved according to skin lesion, eczema can be divided into limitation eczema and universal eczema two major classes.Limitation eczema：
Occur over just privileged site, you can named with position, as hand eczema, pudendum eczema, eczema of scrotum, ear eczema, breast are wet
Rash, perianal eczema, legs eczema etc..Universal eczema：Skin lesion is more, general to send out or distribute in the multiple positions of whole body, as coin is wet
Rash, autosensitization dermatitis, weary lipid eczema.
Eczematosis is because of complexity, still easy recurrent exerbation after treatment improves, hardly possible radical cure.Because respectively there is feature at clinical form and position,
Therefore medication varies with each individual.Currently, there is following three kinds of therapies：One, general control principle：Find possible inducement, such as building ring
Border, living habit, diet, hobby, thought mood etc., and whether there is or not chronic lesions and internal organs disease.Two, interior to use therapy：
It selects antihistamine antipruritic, coordinates or be used alternatingly for two kinds when necessary, universal eczema is orally available or injects glucocorticoid, but
It should not be used for a long time.Three, Topical therapy：Appropriate dosage forms and drug are selected according to skin lesion situation, acute eczema local physiological brine,
3% boric acid or 1：2000~1：The flushing of 10000 liquor potassic permanganates, soak, calamine lotion convergence, protection；It is subacute, chronic
Eczema is using suitable glucocorticoid creme, burnt oil-like formulations or immunomodulator, secondary infection person's added with antibiotic preparation.
There is following drawback according to three of the above therapy：The first prevention be only capable of by adjusting daily life work and rest,
Eating habit etc. prevents the patient for not yet suffering from eczema；Although wet to treating with the antihistamine of therapy kind in second
Rash has certain effect, but prodigious side effect can be also generated to human body, lethargic sleep and it is drowsiness be common sympton, further include headache,
Dry, eye-blurred, vomiting, constipation, diarrhea, dysuria and stimulation, some may may also suffer palpitaition, arrhythmia cordis,
Blood pressure increases, allergic reaction, dizzy, amentia, depression, and sleep disorder trembles, and twitches, hematologic disease and hepatosis,
Children's last very long is overexcited, and the negative effect that this drug generates children and over-65s adult is more
Strongly, if patient when taking the drug with other drugs or mixed food when, Different Effects may be will produce；And it is oral or
Inject glucocorticoid, be utilized glucocorticoid be in body it is particularly important it is a kind of adjust molecule, its hair to body
It educates, grow, being metabolized and immune function etc. plays important regulative, being the most important adjusting hormone of Systemic stress response, but
It is oral or injects improper, glucocorticoid can brings following common side effect and harm to human body：Central obesity, blood glucose
It increases, gastric ulcer, hypertension, osteoporosis, excited, insomnia, rattiness symptom occurs in spirit, inhibits immune, skin occurs
There is glaucoma, cataract etc. in acne, crinosity, blue spot, eyes；The third, is although calamine lotion does not have apparent side effect,
But when being fully recovered soon using calamine lotion number excessive (normal condition lower day 3-4 times) or fash daily, skin can be felt
It is very tight；Hair position is unusable, and hair is avoided to lump；If largely exudation, rotten to the corn, incrustation position should not also make at skin
With；Therefore can be relatively more using the limitation of calamine lotion convergence, protection, and effect is not too much apparent；The third is mainly used
The Topical therapy of glucocorticoid creme, burnt oil-like formulations or immunomodulator is smeared in eczema affected part, existing for existing market
Tacrolimus paste, pimecrolimus ointment are long with healing time, adverse reaction is more, easy anaphylaxis skin is unusable, cure
It the limitations such as can also recur afterwards.
Invention content
It is an object of the invention to overcome the deficiencies of the prior art and provide a kind of eczema ointment and preparation method thereof, with
It solves drug side-effect great Yi existing in the prior art and causes that human body other complication, healing time are long, adverse reaction is more, easy
Anaphylaxis skin is unusable, cure after the technical problems such as can also recur.
The invention discloses following technical schemes；A kind of eczema ointment, including following raw material components：Wormwood, mother chrysanthemum, cicada
Slough off, tacrolimus, Radix Astragali, lotus seeds, Radix Angelicae Sinensis, honey, frankincense, myrrh, waist Huang, Golden Larch Bark, dispersant, glycerin monostearate and
Aloe Vera Gel；Wherein, the weight content of each raw material component is：
Further, in order to make the drug effect of each raw material component play optimum efficiency, the weight content of each raw material component is：
Further, to make dispersant have excellent physiological inertia, it is not involved in human metabolism, and there is excellent life
Object compatibility does not form human skin any stimulation, and dispersant selects polyvinylpyrrolidone, in order to make eczema medicine obtained
Cream can lotion fine and smooth lubricious, glycerin monostearate and Aloe Vera Gel are according to mass ratio 2:1 carries out mixture.
Wherein, drug effect of each raw material component played in ointment of the present invention is as follows：
Wormwood has the function of restraining and sterilizing bacteria, has very strong inhibiting effect to a variety of pathogenic dermatophytes, can treat
Multiple dermatosis, folium artemisiae argyi decoction external application can control wet sore mange, removing dampness to stop itchin, the substances such as volatile oil contained in folium artemisiae argyi, can be very
Good prevention and improvement eczema symptom.
Mother chrysanthemum, contains volatile oil, containing alantol, chrysanthanone, α-firpene, camphor, borneol, lauro lene etc. in oil, still lactone containing chrysanthemum,
The diseases such as scabies, dark sore are had very strong curative effect by chrysanthemum element A, acaciin, linarin, chrysanthemum glucoside, cyanidenon, energy wind-dispelling removing toxic substances.
Cicada slough can control measles without adequate eruption, rubella itch.
Tacrolimus, treatment chronic eczema have Immunosuppressant therapy, anti-inflammatory and itching-relieving action.Tacrolimus is immune
Conditioning agent, structure system macrolides have the characteristics that relative molecular mass is small, percutaneous permeability is good, are suitable for external application.It is made
It with mechanism is combined with the cytoplasmic protein of T lymphocytes, inhibits the phosphate esterase active of calcineurin, and then inhibit
The expression and release of cytokine profiles and inflammatory mediator, generate powerful anti-inflammatory effect；It can promote the conjunction of skin collagen simultaneously
At the recovery with skin barrier function.The anti-inflammatory effect of the medicine both alternative steroids preparation, in turn avoids long-term external application hormone
Adverse reaction caused by preparation.Tacrolimus paste is macrolides external application immunomodulator, treatment atopic dermatitis safety
Effectively.
Radix Astragali is common help class Chinese medicine, the work(with tonifying Qi and lifting yang, strengthening exterior and reducing sweat, torr sore myogenic, diuresis detumescence
Effect.Contain sucrose, glucuronic acid, a variety of amino acid, folic acid and various trace elements in Radix Astragali, has stimulating central nervous system, carries
The phagocytic function of high leukocytic and reticuloendothelial system, be improved body immunity, expansion blood vessel, improve skin blood cycle,
A variety of effects such as diuresis are given birth to Radix Astragali and are focused on outside up to skin, and hidroschesis consolidates table, torr sore myogenic.According to clinical verification, to some skin diseases
It is effective in cure.
Lotus seeds have the effect of clearing heart fire, mental-tranquilization, especially have fine curative effect to damp and hot caused eczema.
Radix Angelicae Sinensis, containing volatile oil, esters, Yan acid, retinoid etc., angelica extract can reduce vasopermeability, inhibit to cause
The release of scorching substance, to play anti-inflammatory effect.Radix Angelicae Sinensis decoction has inhibiting effect to various bacteria, and can promote immunity of organism
Function.
Honey contains 0.1%~0.4% ablastins, can inhibit the growth of bacterium, be applied on human skin, can
With antibacterial, wound infection is prevented, moreover it is possible to promote skin growth, help wound healing.
Frankincense, also name horse hair is fragrant, nipple is fragrant, bathes perfume (or spice) etc., the arduous temperature of nature and flavor enters the heart, liver, the spleen channel, and function promoting blood circulation regulating the qi flowing in the channels stops
Bitterly, dispersing swelling and dissipating binds myogenic, frankincense grind to the powder external application, do not close up long after can treating blister ulcer ulceration, can removing necrosis, promoting granulation.The present invention's
Frankincense is added in eczema ointment can effectively treat because of the infection that eczema scratches rear apparent dotted exudation and small rotten to the corn face is caused, scorching
Disease is apparent, therefore warts, purulence scab, epifolliculitis, the furuncle etc. formed.
Myrrh has the effect of scattered stasis pain, detumescence and promoting granulation；It can enhance promoting blood circulation ability with frankincense, be usually used in promoting blood circulation and stopping pain,
Ulcer sores are treated, it can swelling and pain relieving；The Radix Angelicae Sinensis being equipped with again in we can treat acute skin infection, such as carbuncle furuncle, erysipelas；It is right
Eczema curative effect that the present invention is directed to it is further preferred that.
Waist is yellow, also known as " realgar ", " orpiment ", " bright hero ", " red orpiment ", the desinsection that can detoxify, eliminating dampness, antipruritic, corruption of dispelling, and cures mainly slow
The skin diseases such as property eczema, herpes zoster, fungal infection.
Golden Larch Bark is the bark or root skin of pinaceae plant golden larch, and Golden Larch Bark has desinsection antipruritic, control tinea itch, eczema,
The effect of leprosy dysentery head, neurodermatitis.
Polyvinylpyrrolidone has excellent physiological inertia, is not involved in human metabolism, and have excellent biofacies
Capacitive does not form any stimulation to skin, mucous membrane, eye etc., and polyvinylpyrrolidone is added in this side can prevent the heavy of particle
Drop and cohesion, make each raw material component preferably be fused into emulsifiable paste shape.
Glycerin monostearate is a kind of surfactant of nonionic.It is existing hydrophilic and has lipophilic group, has
The multiple functions such as wetting, emulsification, blistering, are used as emulsifier in medical paste, and lotion can be made fine and smooth, lubricious.
Aloe Vera Gel is product made of extraction in a kind of natural herbs " aloe ", and purity is very high, nontoxic secondary to make
With it festers to incised wound, scratch, scald, wound, operative scar etc. has apparent booster action, also has good anti-inflammatory
Disinfecting and beauty effect, safe and reliable, Aloe Vera Gel is added in the ointment component of the present invention can promote to scald skin histology
Restore, avoids scar.
The invention discloses a kind of preparation methods of eczema ointment, including following preparation process：
1) yellow cicada slough, Radix Astragali, Radix Angelicae Sinensis, frankincense, myrrh, waist and Golden Larch Bark are weighed and carries out co-grinding, will be mixed after crushing
It closes object to pour into the alcohol solution dipping 24 hours for being 75~80% with mass concentration in beaker, mixture is then transferred to three again
It is heated at reflux in mouth flask；Filtering retains filtrate, and Chinese medical extract I is obtained after evaporating solvent；
2) it weighs the wormwood after drying and mother chrysanthemum is put into pot and is decocted with clear water, after small fire boiling decocts 2~3 hours, fishing
Wormwood and mother chrysanthemum, aqueous is taken to obtain water extract II after concentration；
3) Chinese medical extract I and water extract II are put into beaker and are merged, and the lotus seeds pulverized and honey are fallen
Enter in beaker and is mixed；Obtain confection III；
4) it glycerin monostearate and Aloe Vera Gel is poured into another is contained in the beaker of absolute ethyl alcohol and mix, and will mix
It closes solution and is put into progress ultrasound, heating in Ultrasound Instrument；After being sufficiently mixed, solution IV is obtained；
5) his load weighted Mack department and dispersant are added in confection III, while again fall solution IV obtained
Enter in confection III, be mixed, eczema ointment coarse fodder is obtained after evaporating solvent；
6) eczema ointment coarse fodder is injected in high pressure homogenizer carry out it is high-pressure homogeneous, to get to eczema medicine after aluminium suitcase dress
Cream.
Further, in order to keep cicada slough, Radix Astragali, Radix Angelicae Sinensis, frankincense, myrrh, waist yellow and the active ingredient of Golden Larch Bark is more preferable
Extraction, while in order to avoid because temperature is excessively high and heating time long influence drug effect, the temperature control being heated at reflux in step 1)
System is at 85~90 DEG C, and the time control of reflux was at 2~3 hours.
Further, in order to keep ointment lotion made from the later stage uniform, consistency is suitable, the water extraction in step 2) after concentration
II fixing fabric structure of object is in 10~15mm.
Further, in order to keep ointment lotion made from the later stage uniform, being not in particle precipitation influences to use, step 3)
In the lotus seeds pulverized cross 120 mesh screens.
Further, in order to make IV uniform and smooth of solution obtained, ultrasonic time control is at 15~30 points in step 4)
The temperature of clock, heating is controlled at 40 DEG C.
Further, purer in order to make to be made ointment quality, remaining solvent in it is removed completely, it will in step 5)
Solution IV obtained pours into confection III, is put into after mixing in vacuum drying chamber and carries out evaporation of the solvent, vacuum degree control
System is controlled in 0.3~0.5 atmospheric pressure, temperature at 50~55 DEG C.
Eczema ointment has the advantages that made from preparation method of the present invention：Removing dampness to stop itchin, immunological regulation, it is anti-inflammatory and
Antipruritic, clearing heart fire, mental-tranquilization, promoting blood circulation regulating the qi flowing in the channels analgesic, dispersing swelling and dissipating binds myogenic can for festering caused by itch, warts
Removing necrosis, promoting granulation.Again because eczema is a kind of allergic disease (allergic reaction), after body's immunity is by destroying, body
The allergin in blood cannot be removed, it is anti-that these allergins adhere to the metamorphosis caused on dermovascular basilar memebrane
It answers.Eczema ointment produced by the present invention mainly uses traditional Chinese medicine ingredients as raw material, and middle the effective elements of the medicine is all that some are organic
The macromolecular of object, it contains many active groups, can adhere to the allergin in blood, forms the compound of bigger, this
Compound is excreted by the diuresis of Chinese medicine from kidney, so the phenomenon that treatment of eczema is not in repeatedly, and its
Chinese medicine in middle each raw material component is plant mostly, seldom can suffer from the patient of eczema for a long time there is a phenomenon where damage liver kidney,
Smearing the eczema ointment of the present invention can cure the disease root, and will not bring any side effect.
Specific implementation mode
It elaborates below to the embodiment of the present invention, the present embodiment is carried out lower based on the technical solution of the present invention
Implement, gives detailed embodiment and specific operating process, but protection scope of the present invention is not limited to following implementation
Example.
Embodiment 1
Present embodiment discloses a kind of eczema ointments, including following raw material components for embodiment 1：Wormwood, mother chrysanthemum, cicada slough, he
Ke Mosi, Radix Astragali, lotus seeds, Radix Angelicae Sinensis, honey, frankincense, myrrh, waist Huang, Golden Larch Bark, dispersant, glycerin monostearate and aloe
Glue；
Wherein, the weight content of each raw material component is：
Wherein, dispersant is polyvinylpyrrolidone, and glycerin monostearate and Aloe Vera Gel are according to mass ratio 2:1 carries out
Mixture.
Present embodiment discloses a kind of preparation methods of eczema ointment, including following preparation process：
1) yellow cicada slough, Radix Astragali, Radix Angelicae Sinensis, frankincense, myrrh, waist and Golden Larch Bark are weighed and carries out co-grinding, will be mixed after crushing
It closes object to pour into the alcohol solution dipping 24 hours for being 75% with mass concentration in beaker, mixture is then transferred to three mouthfuls of burnings again
It is heated at reflux in bottle；Filtering retains filtrate, and Chinese medical extract I is obtained after evaporating solvent；
2) it weighs the wormwood after drying and mother chrysanthemum is put into pot and is decocted with clear water, after small fire boiling decocts 2 hours, fish for Chinese mugwort
Grass and mother chrysanthemum, aqueous obtain water extract II after concentration；
3) Chinese medical extract I and water extract II are put into beaker and are merged, and the lotus seeds pulverized and honey are fallen
Enter in beaker and is mixed；Obtain confection III；
4) it glycerin monostearate and Aloe Vera Gel is poured into another is contained in the beaker of absolute ethyl alcohol and mix, and will mix
It closes solution and is put into progress ultrasound, heating in Ultrasound Instrument；After being sufficiently mixed, solution IV is obtained；
5) his load weighted Mack department and dispersant are added in confection III, while again fall solution IV obtained
Enter in confection III, be mixed, eczema ointment coarse fodder is obtained after evaporating solvent；
6) eczema ointment coarse fodder is injected in high pressure homogenizer carry out it is high-pressure homogeneous, to get to eczema medicine after aluminium suitcase dress
Cream.
Wherein, at 85 DEG C, the time of reflux is 2 hours for the temperature control being heated at reflux in step 1).
Wherein, II fixing fabric structure of water extract in step 2) after concentration is in 10mm.
Wherein, the lotus seeds pulverized in step 3) cross 120 mesh screens.
Wherein, at 15 minutes, the temperature of heating was controlled at 40 DEG C time control ultrasonic in step 4).
Wherein, solution IV obtained is poured into confection III in step 5), vacuum drying chamber is put into after mixing
Middle carry out evaporation of the solvent, vacuum degree control are controlled in 0.3 atmospheric pressure, temperature at 50 DEG C.
Embodiment 2
Present embodiment discloses a kind of eczema ointments, including following raw material components for embodiment 2：Wormwood, mother chrysanthemum, cicada slough, he
Ke Mosi, Radix Astragali, lotus seeds, Radix Angelicae Sinensis, honey, frankincense, myrrh, waist Huang, Golden Larch Bark, dispersant, glycerin monostearate and aloe
Glue；Wherein, the weight content of each raw material component is：
Wherein, dispersant is polyvinylpyrrolidone, and glycerin monostearate and Aloe Vera Gel are according to mass ratio 2:1 carries out
Mixture.
Present embodiment discloses a kind of preparation methods of eczema ointment, including following preparation process：
1) yellow cicada slough, Radix Astragali, Radix Angelicae Sinensis, frankincense, myrrh, waist and Golden Larch Bark are weighed and carries out co-grinding, will be mixed after crushing
It closes object to pour into the alcohol solution dipping 24 hours for being 80% with mass concentration in beaker, mixture is then transferred to three mouthfuls of burnings again
It is heated at reflux in bottle；Filtering retains filtrate, and Chinese medical extract I is obtained after evaporating solvent；
2) it weighs the wormwood after drying and mother chrysanthemum is put into pot and is decocted with clear water, after small fire boiling decocts 3 hours, fish for Chinese mugwort
Grass and mother chrysanthemum, aqueous obtain water extract II after concentration；
3) Chinese medical extract I and water extract II are put into beaker and are merged, and the lotus seeds pulverized and honey are fallen
Enter in beaker and is mixed；Obtain confection III；
4) it glycerin monostearate and Aloe Vera Gel is poured into another is contained in the beaker of absolute ethyl alcohol and mix, and will mix
It closes solution and is put into progress ultrasound, heating in Ultrasound Instrument；After being sufficiently mixed, solution IV is obtained；
5) his load weighted Mack department and dispersant are added in confection III, while again fall solution IV obtained
Enter in confection III, be mixed, eczema ointment coarse fodder is obtained after evaporating solvent；
6) eczema ointment coarse fodder is injected in high pressure homogenizer carry out it is high-pressure homogeneous, to get to eczema medicine after aluminium suitcase dress
Cream.
Wherein, at 90 DEG C, the time of reflux is 3 hours for the temperature control being heated at reflux in step 1).
Wherein, II fixing fabric structure of water extract in step 2) after concentration is in 15mm.
Wherein, the lotus seeds pulverized in step 3) cross 120 mesh screens.
Wherein, at 30 minutes, the temperature of heating was controlled at 40 DEG C time control ultrasonic in step 4).
Wherein, solution IV obtained is poured into confection III in step 5), vacuum drying chamber is put into after mixing
Middle carry out evaporation of the solvent, vacuum degree control are controlled in 0.5 atmospheric pressure, temperature at 55 DEG C.
Embodiment 3
Present embodiment discloses a kind of eczema ointments, including following raw material components for embodiment 3：Wormwood, mother chrysanthemum, cicada slough, he
Ke Mosi, Radix Astragali, lotus seeds, Radix Angelicae Sinensis, honey, frankincense, myrrh, waist Huang, Golden Larch Bark, dispersant, glycerin monostearate and aloe
Glue；Wherein, the weight content of each raw material component is：
Wherein, dispersant is polyvinylpyrrolidone, and glycerin monostearate and Aloe Vera Gel are according to mass ratio 2:1 carries out
Mixture.
Present embodiment discloses a kind of preparation methods of eczema ointment, including following preparation process：
1) yellow cicada slough, Radix Astragali, Radix Angelicae Sinensis, frankincense, myrrh, waist and Golden Larch Bark are weighed and carries out co-grinding, will be mixed after crushing
It closes object to pour into the alcohol solution dipping 24 hours for being 78% with mass concentration in beaker, mixture is then transferred to three mouthfuls of burnings again
It is heated at reflux in bottle；Filtering retains filtrate, and Chinese medical extract I is obtained after evaporating solvent；
2) it weighs the wormwood after drying and mother chrysanthemum is put into pot and is decocted with clear water, after small fire boiling decocts 3 hours, fish for Chinese mugwort
Grass and mother chrysanthemum, aqueous obtain water extract II after concentration；
3) Chinese medical extract I and water extract II are put into beaker and are merged, and the lotus seeds pulverized and honey are fallen
Enter in beaker and is mixed；Obtain confection III；
4) it glycerin monostearate and Aloe Vera Gel is poured into another is contained in the beaker of absolute ethyl alcohol and mix, and will mix
It closes solution and is put into progress ultrasound, heating in Ultrasound Instrument；After being sufficiently mixed, solution IV is obtained；
5) his load weighted Mack department and dispersant are added in confection III, while again fall solution IV obtained
Enter in confection III, be mixed, eczema ointment coarse fodder is obtained after evaporating solvent；
6) eczema ointment coarse fodder is injected in high pressure homogenizer carry out it is high-pressure homogeneous, to get to eczema medicine after aluminium suitcase dress
Cream.
Wherein, at 88 DEG C, the time of reflux is 3 hours for the temperature control being heated at reflux in step 1).
Wherein, II fixing fabric structure of water extract in step 2) after concentration is in 13mm.
Wherein, the lotus seeds pulverized in step 3) cross 120 mesh screens.
Wherein, at 25 minutes, the temperature of heating was controlled at 40 DEG C time control ultrasonic in step 4).
Wherein, solution IV obtained is poured into confection III in step 5), vacuum drying chamber is put into after mixing
Middle carry out evaporation of the solvent, vacuum degree control are controlled in 0.4 atmospheric pressure, temperature at 53 DEG C.
Embodiment 4
Present embodiment discloses a kind of eczema ointments, including following raw material components for embodiment 4：Wormwood, mother chrysanthemum, cicada slough, he
Ke Mosi, Radix Astragali, lotus seeds, Radix Angelicae Sinensis, honey, frankincense, myrrh, waist Huang, Golden Larch Bark, dispersant, glycerin monostearate and aloe
Glue；Wherein, the weight content of each raw material component is：
Wherein, dispersant is polyvinylpyrrolidone, and glycerin monostearate and Aloe Vera Gel are according to mass ratio 2:1 carries out
Mixture.
Present embodiment discloses a kind of preparation methods of eczema ointment, including following preparation process：
1) yellow cicada slough, Radix Astragali, Radix Angelicae Sinensis, frankincense, myrrh, waist and Golden Larch Bark are weighed and carries out co-grinding, will be mixed after crushing
It closes object to pour into the alcohol solution dipping 24 hours for being 76% with mass concentration in beaker, mixture is then transferred to three mouthfuls of burnings again
It is heated at reflux in bottle；Filtering retains filtrate, and Chinese medical extract I is obtained after evaporating solvent；
2) it weighs the wormwood after drying and mother chrysanthemum is put into pot and is decocted with clear water, after small fire boiling decocts 2 hours, fish for Chinese mugwort
Grass and mother chrysanthemum, aqueous obtain water extract II after concentration；
3) Chinese medical extract I and water extract II are put into beaker and are merged, and the lotus seeds pulverized and honey are fallen
Enter in beaker and is mixed；Obtain confection III；
4) it glycerin monostearate and Aloe Vera Gel is poured into another is contained in the beaker of absolute ethyl alcohol and mix, and will mix
It closes solution and is put into progress ultrasound, heating in Ultrasound Instrument；After being sufficiently mixed, solution IV is obtained；
5) his load weighted Mack department and dispersant are added in confection III, while again fall solution IV obtained
Enter in confection III, be mixed, eczema ointment coarse fodder is obtained after evaporating solvent；
6) eczema ointment coarse fodder is injected in high pressure homogenizer carry out it is high-pressure homogeneous, to get to eczema medicine after aluminium suitcase dress
Cream.
Wherein, at 86 DEG C, the time of reflux is 2 hours for the temperature control being heated at reflux in step 1).
Wherein, II fixing fabric structure of water extract in step 2) after concentration is in 12mm.
Wherein, the lotus seeds pulverized in step 3) cross 120 mesh screens.
Wherein, at 20 minutes, the temperature of heating was controlled at 40 DEG C time control ultrasonic in step 4).
Wherein, solution IV obtained is poured into confection III in step 5), vacuum drying chamber is put into after mixing
Middle carry out evaporation of the solvent, vacuum degree control are controlled in 0.3 atmospheric pressure, temperature at 52 DEG C.
One, for the clinical test of eczema patients.
1, subjects：250 eczema patients, man 165, female 85.
2, therapy
250 eczema patients are divided by treatment group's (totally four groups of Examples 1 to 4) and control group using the principle of parallel control
(totally one group), every group of 50 patients.
Through statistical analysis, each group Gender, age, the course of disease, the there was no significant difference (P such as grading>0.05), have
There is comparativity.
Treatment group：After being dried within 5 minutes with warm water's immersion affected part, eczema ointment produced by the present invention is smeared in affected part, often
Day 2 times, once in the morning and once at night.
Control group：The wet clear white skin care moisturizing rash cream in shop of painting ring, application method and the same treatment group of the frequency.
3, criterion：
(1) effective：Symptom disappears at eczema, and skin heals completely, no scar；
(2) effectively：Cardinal symptom disappears, and eczema affected part skin heals substantially, there is slight trace；
(3) invalid：Eczema symptom is not improved.
Data after contrast test are recorded, the affected part number of days used that fully recovers is fewer, rehabilitation people in same time
Number more at most drug effect is better.
4, result on trial：It is shown in Table 1.
Table 1
The data that are recorded by table 1 are it is found that behind the eczema ointment coating affected part that the present invention is prepared, in three weeks, patient
Illness all disappear, skin heals completely at eczema, and the ointment slowly effect in control group, and need application healing time compared with
It is long, and found in later stage long-term observation, the same affected part of some patients is also reoccurred the illness of the eczema.
Two, typical case：
Huang, man, 57 years old, first visit on March 20 in 2012, both hands eczema recurrent exerbation more than 6 years, patient's both hands kermesinus
Papule, itch flowing water, the apparent scratch in surface, skin lesion concomitant fertilizer in part is thick, and symptom slightly subtracts after hormone, the treatment of calcium agent antiallergic,
But it recurs quickly.Once it was diagnosed as " chronic eczema " in local hospital, through with the various therapies of traditional Chinese and western medicine Orally taken and externally, failing to control
More, frequent recurrent exerbation, it is touching not to be cured.Tongue nature is light, moss thin yellow, soft and thready pulse number.Card belongs to retention of damp-heat in the interior, and weight in wet base is in heat.Read preceding doctor
Zhu Fangduozhi is with eliminating dampness and heat, the agent of strengthening spleen and nourishing blood wind-dispelling.Patient with weak shortness of breath, may often consume with the medicine impairment of the spleen of the clear profit of informal dress
Gas is related.Control suitable QI invigorating wind-dispelling, clearing damp heat-clearing.It smears eczema ointment prepared by the present invention to fully recover after three weeks, and in later observations
One month in occur without any erythema and pruritis.
The Qin, female, 35 years old, government functionary need to often go out, and belong to easy allergic skin, especially in spring and summer season, neck and
Often there is the erythema of most intensive grain grain sizes in the back of the hand, and substrate flush, gradually fusion is in blocks, and itch is hard to bear, the water in erythema
After blister point is scratched, pus outflow causes eczema area to infect bigger, anti-inflammatory ointment can be also smeared when occurring eczema symptom before,
Scratchiness can be mitigated and further deteriorated, but can not be eradicated, after smearing eczema ointment prepared by the present invention, recovery from illness in two weeks,
Continue to smear one week, symptom is eradicated completely, and is observed in 1 year later, is not recurred again.
Lee, man, 45 years old, is engaged in agriculture, and because managing labor service for a long time and not maintained, brothers are easy under hygrothermal environment
Eczema, medical history 2 years are recurred, symptom is the back of the hand portion and instep rough surface, covers the scales of skin that peel off, feels acute pruritus, smears the present invention
After the eczema ointment of preparation, recovery from illness in two weeks, and observed in 1 year later, it does not recur again.
Guo, man, 29 years old, calf eczema recurrent exerbation more than 2 years, in the damp and hot weather of spring and summer, patient's calf affected part was risen
Kermesinus papule, pachyderma, itch smear eczema ointment prepared by the present invention and are completely recovered after three weeks, and in later observations
One month in occur without any erythema and pruritis.
The eczema ointment of the present invention is well-established by neighbouring group at present, after smearing can removing dampness to stop itchin, it is immunological regulation, anti-
It is scorching and antipruritic, clearing heart fire, mental-tranquilization, promoting blood circulation regulating the qi flowing in the channels analgesic, dispersing swelling and dissipating binds myogenic, for bursting caused by itch, warts
It is rotten, it can removing necrosis, promoting granulation.Eczema ointment produced by the present invention mainly uses traditional Chinese medicine ingredients as raw material, and middle the effective elements of the medicine is all
It is the macromolecular of some organic matters, it contains many active groups, can adhere to the allergin in blood, forms answering for bigger
Object is closed, this compound is excreted by the diuresis of Chinese medicine from kidney, so the treatment of eczema is not in repeatedly
Phenomenon, and the Chinese medicine wherein in each raw material component is plant mostly, seldom can for a long time be suffered from wet there is a phenomenon where damaging liver kidney
The patient of rash, smearing the eczema ointment of the present invention can cure the disease root, and will not bring any side effect.
Claims (9)
1. a kind of eczema ointment, which is characterized in that including following raw material components：Wormwood, mother chrysanthemum, cicada slough, tacrolimus, Radix Astragali,
Lotus seeds, Radix Angelicae Sinensis, honey, frankincense, myrrh, waist Huang, Golden Larch Bark, dispersant, glycerin monostearate and Aloe Vera Gel；Wherein, described
The weight content of each raw material component is：
2. eczema ointment as described in claim 1, which is characterized in that the weight content of each raw material component is：
3. eczema ointment as described in claim 1, which is characterized in that the dispersant is polyvinylpyrrolidone, the list
Tristerin and Aloe Vera Gel are according to mass ratio 2:1 carries out mixture.
4. a kind of preparation method of the eczema ointment as described in claim 1-3 is any, which is characterized in that walked including following preparation
Suddenly：
1) yellow cicada slough, Radix Astragali, Radix Angelicae Sinensis, frankincense, myrrh, waist and Golden Larch Bark are weighed and carries out co-grinding, by mixture after crushing
The alcohol solution dipping 24 hours for being 75~80% with mass concentration in beaker is poured into, mixture is then transferred to three mouthfuls of burnings again
It is heated at reflux in bottle；Filtering retains filtrate, and Chinese medical extract I is obtained after evaporating solvent；
2) it weighs the wormwood after drying and mother chrysanthemum is put into pot and is decocted with clear water, after small fire boiling decocts 2~3 hours, fish for Chinese mugwort
Grass and mother chrysanthemum, aqueous obtain water extract II after concentration；
3) Chinese medical extract I and water extract II are put into beaker and are merged, and the lotus seeds pulverized and honey are poured into burning
It is mixed in cup；Obtain confection III；
4) it glycerin monostearate and Aloe Vera Gel is poured into another is contained in the beaker of absolute ethyl alcohol and mix, and will be described mixed
It closes solution and is put into progress ultrasound, heating in Ultrasound Instrument；After being sufficiently mixed, solution IV is obtained；
5) his load weighted Mack department and dispersant are added in the confection III, while again fall solution IV obtained
Enter in the confection III, be mixed, eczema ointment coarse fodder is obtained after evaporating solvent；
6) the eczema ointment coarse fodder is injected in high pressure homogenizer carry out it is high-pressure homogeneous, to get to eczema medicine after aluminium suitcase dress
Cream.
5. the preparation method of eczema ointment as claimed in claim 4, which is characterized in that the temperature control being heated at reflux in step 1)
At 85~90 DEG C, the time of reflux is 2~3 hours.
6. the preparation method of eczema ointment as claimed in claim 4, which is characterized in that the water extract II in step 2) after concentration
Fixing fabric structure is in 10~15mm.
7. the preparation method of eczema ointment as claimed in claim 4, which is characterized in that the lotus seeds mistake pulverized in step 3)
120 mesh screens.
8. the preparation method of eczema ointment as claimed in claim 4, which is characterized in that ultrasonic time control is 15 in step 4)
~30 minutes, the temperature of heating was controlled at 40 DEG C.
9. the preparation method of eczema ointment as claimed in claim 4, which is characterized in that pour into solution IV obtained in step 5)
It is put into confection III, after mixing in vacuum drying chamber and carries out evaporation of the solvent, vacuum degree control is big at 0.3~0.5
Air pressure, temperature are controlled at 50~55 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810520335.4A CN108379350A (en) | 2018-05-28 | 2018-05-28 | A kind of eczema ointment and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810520335.4A CN108379350A (en) | 2018-05-28 | 2018-05-28 | A kind of eczema ointment and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108379350A true CN108379350A (en) | 2018-08-10 |
Family
ID=63072007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810520335.4A Withdrawn CN108379350A (en) | 2018-05-28 | 2018-05-28 | A kind of eczema ointment and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108379350A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108355042A (en) * | 2018-05-28 | 2018-08-03 | 陈雨薇 | A kind of anti-inflammatory analgetic ointment and preparation method thereof |
| CN108355125A (en) * | 2018-05-28 | 2018-08-03 | 陈雨薇 | Anti- chap ointment of one kind and preparation method thereof |
| CN113476295A (en) * | 2021-02-01 | 2021-10-08 | 广西励领农业科技有限公司 | Intelligent infrared ultrasonic moxibustion instrument device and physiotherapy method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804166A (en) * | 2010-05-05 | 2010-08-18 | 余静 | Traditional Chinese medicine composition for treating dermatitis and eczema of infants |
| CN103830506A (en) * | 2014-01-24 | 2014-06-04 | 河南科技大学第一附属医院 | Composite ointment used for rapid wound heal and preparation method thereof |
| CN104510831A (en) * | 2013-10-07 | 2015-04-15 | 青岛萨恩诺瑞尔生物质化能源有限公司 | Lithospermum ointment and preparation method thereof |
| CN105963480A (en) * | 2016-06-24 | 2016-09-28 | 安徽高山药业有限公司 | Pine needle compound ointment capable of relieving swelling and pain and preparation method |
-
2018
- 2018-05-28 CN CN201810520335.4A patent/CN108379350A/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804166A (en) * | 2010-05-05 | 2010-08-18 | 余静 | Traditional Chinese medicine composition for treating dermatitis and eczema of infants |
| CN104510831A (en) * | 2013-10-07 | 2015-04-15 | 青岛萨恩诺瑞尔生物质化能源有限公司 | Lithospermum ointment and preparation method thereof |
| CN103830506A (en) * | 2014-01-24 | 2014-06-04 | 河南科技大学第一附属医院 | Composite ointment used for rapid wound heal and preparation method thereof |
| CN105963480A (en) * | 2016-06-24 | 2016-09-28 | 安徽高山药业有限公司 | Pine needle compound ointment capable of relieving swelling and pain and preparation method |
Non-Patent Citations (9)
| Title |
|---|
| 吴丽丽等: "《明明白白学中医.4，中药方剂篇》", 30 June 2016, 广东科技出版社 * |
| 国医编委会: "《家庭生活窍门与禁忌全知道》", 31 January 2016, 黑龙江科学技术出版社 * |
| 李冈荣: "《800种中草药彩色图鉴：白金增藏版》", 31 January 2017, 福建科学技术出版社 * |
| 柴瑞震: "《《黄帝内经》和《本草纲目》中的中药养生全典》", 31 January 2014, 黑龙江科学技术出版社 * |
| 熊佑清等: "《芦荟》", 31 July 1998, 中国农业大学出版社 * |
| 石惠颖等: "《中药学四易口诀》", 30 June 2017, 中国医药科技出版社 * |
| 贾育松: "《创伤感染中医临床实用手册》", 31 March 2016, 中医古籍出版社 * |
| 魏太星等: "《医生专用药物手册》", 31 January 2015, 河南科学技术出版社 * |
| 黄文达: "《香草植物就要这样玩》", 30 November 2016, 福建科学技术出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108355042A (en) * | 2018-05-28 | 2018-08-03 | 陈雨薇 | A kind of anti-inflammatory analgetic ointment and preparation method thereof |
| CN108355125A (en) * | 2018-05-28 | 2018-08-03 | 陈雨薇 | Anti- chap ointment of one kind and preparation method thereof |
| CN113476295A (en) * | 2021-02-01 | 2021-10-08 | 广西励领农业科技有限公司 | Intelligent infrared ultrasonic moxibustion instrument device and physiotherapy method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
| CN102145111B (en) | Traditional Chinese medicine composition for treating colpitis mycotica and preparation method thereof | |
| CN103041173B (en) | Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof | |
| CN102145064B (en) | Traditional Chinese medicine composition for treating senile vaginitis and preparation method thereof | |
| CN100404054C (en) | Decoction Chinese medicine sterilizing antiphlogistic, preparation and use thereof | |
| CN101455738B (en) | Traditional Chinese medicine composition for treating eczema and preparation method thereof | |
| CN103417904B (en) | Traditional Chinese medicine composition for treating chronic cheilitis and preparing method thereof | |
| CN108853404A (en) | A kind of compound Chinese medicinal preparation and preparation method thereof for treating skin and mucous membrane disease | |
| CN102178804A (en) | Chinese medicinal composition for treating perianal eczema and preparation method thereof | |
| CN104739925A (en) | Composition for treating acnes and preparation method for composition | |
| CN103860978B (en) | A kind of Chinese medicine preparation for the treatment of decubital ulcer and preparation method thereof | |
| CN108379350A (en) | A kind of eczema ointment and preparation method thereof | |
| CN106474350A (en) | A kind of plant antibiotic compound spray and preparation method thereof | |
| CN102178877B (en) | External preparation for treating eczema of scrotum and preparation method thereof | |
| CN103536826B (en) | One is treated colpitic Chinese medicine composition and preparation method thereof | |
| CN104815192A (en) | Pharmaceutical composition for treating hypertension and application of pharmaceutical composition | |
| WO2018137319A1 (en) | Application of sarcococca vagans, chinese medicinal ointment for treating skin disease, preparation method and application thereof | |
| CN104474028B (en) | Ointment for the treatment of skin pruritus and preparation method thereof | |
| CN105662996A (en) | Traditional Chinese medicine mask for treating menstruation-associated acne | |
| CN103877247A (en) | Medicine for treating bedsore and preparation method thereof | |
| CN106620633A (en) | Skin repairing cream for tumor patients and preparation method of skin repairing cream | |
| CN113616774B (en) | Antibacterial composition containing plant stem cells, maintenance antibacterial liquid and preparation method thereof | |
| CN103721138B (en) | A kind of traditional Chinese medicine for external application and its preparation method treating rosacea | |
| CN103212031A (en) | Traditional Chinese medicine composition for treating primary nephrotic syndrome and preparation method thereof | |
| CN115518127A (en) | Antibacterial, anti-inflammatory, detumescence and itching relieving cream and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180810 |